Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Money

Sealantis Sells for $25 Million

February 6, 2019
AlgaeIndustryMagazine.com

The Sealantis team. Photo: Nitzan Zohar, Technion spokesperson’s office

Sealantis, which was established in Israel on the basis of technology developed at the Technion Institute, has been sold for US$25 million and royalties from future sales to Advanced Medical Solutions Group from England.

Sealantis develops medical adhesives based on technology from the Technion, which mimics the mechanism of adhesion of algae to rocks in water. “This is fundamental research inspired by a natural phenomenon that developed into applied technology, was patented and eventually became a product that will enable hundreds of thousands of patients to be treated.”

AMS, the acquiring company, is a manufacturer of innovative and technologically advanced products for the global surgical, wound closure and advanced wound care markets. This is their first acquisition in Israel, and Sealantis will be an innovation center for the multinational group. AMS’s products are sold in more than 75 countries, and the group has more than 600 employees.

Sealantis develops medical device products, based on a proprietary platform of alga-mimetic tissue adhesives, for a variety of applications in surgical adhesion. The company was established under the auspices of the AMIT Institute at the Technion, under the leadership of Prof. Havazelet Bianco-Peled, a world-renowned expert in biomedical polymers, from the Faculty of Chemical Engineering at the Technion.

The company’s present focus is on surgical seals designed to stop bleeding, prevent leakage of digestive tract contents into the abdominal cavity, prevent leakage of spinal fluid, and a variety of other applications.

The leading advantage of the technology is the fact that it is based on a polymer produced from algae, which does not contain proteins, and therefore the risk of infection or allergy is significantly lower than that of competing products produced from animals. The product does not require refrigerated transport and storage, it can be applied by spreading or spraying and is also suitable for use in laparoscopic surgery.

Tomer Fuchs, CEO of Sealantis, said that the connection with AMS increases the potential impact of the company’s products. “The journey of Sealantis is underway. The merger into AMS is an important milestone in the realization of our vision to enable medical teams around the world to prevent serious surgical complications thanks to Sealantis’ products.

“Following the merger, AMS will enjoy our scientific and engineering capabilities as an Israeli start-up company in the field of biotechnology, which includes innovation and the ability to bring simple and original solutions to complex challenges. AMS plans to expand operations in Israel, enabling it to expand into new, significant directions.”

More Like This…

Copyright ©2010-2020 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Baillargues, France’s Microphyt, a leading company in microalgae-based natural solutions for nutrition and well-being, has announced a fundraising of €28.5 million (US$32...
Julianna Photopoulos writes in Horizon EU Research and Innovation magazine that UK start-up Skipping Rocks Lab aims to use natural materials extracted from plants and sea...
Paul Brinkmann reports for UPI.com that Florida Atlantic University and three other research schools have launched studies this year to test people who live near the coas...
Mazda U.K. has announced that they are currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promo...
Israeli-based Algatechnologies, Ltd. (Algatech), is teaming up with the Italian R&D company, Sphera Encapsulation S.r.l (Sphera), to develop innovative functional ingredi...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...
Gerard de Souza reports for the Hindustan Times that researchers at the CSIR-National Institute of Oceanography Goa (India) have found a cleaner, cheaper method to grow b...
Milenio.com reports that BiomiTech, a Mexican company, won a prestigious innovation award for its air purification system at the Contamination Expo Series 2018 held in Bi...
Bloomberg News reports that a newly approved Chinese drug for Alzheimer’s will start clinical trials in the U.S. and Europe this year as the country’s first novel therapy...
Laura Sanders reports in Sciencenews.org that using algae as local oxygen factories in the brain might one day lead to therapies for strokes or other damage from too litt...
Biotechnologists from Aarhus University have demonstrated how the rare properties of an atypical light-dependent enzyme can be used with a photo-bio-catalytic continuous ...
Mazda is currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promote the wide-spread adoption of...